Group 1 - The innovative drug concept stocks have seen a surge in popularity, with Zhendong Pharmaceutical rising by 20%, and several other companies like Saily Medical and Qidi Pharmaceutical hitting the daily limit up [1] - Baichuan Intelligent has officially launched the open-source medical enhancement model Baichuan-M2, which has been optimized for private deployment in the medical field, achieving a 57-fold cost reduction compared to the previous dual-node deployment method [1] - Six innovative drugs have entered the public notice period for potential breakthrough therapy designation, including BI 1810631, IN10018, MRG004A, ATG-022, LM-302, and RC148, with MRG004A, ATG-022, and LM-302 being ADC drugs [1]